KROS
Price
$13.65
Change
-$0.37 (-2.64%)
Updated
May 9 closing price
Capitalization
554.4M
82 days until earnings call
KURA
Price
$5.76
Change
-$0.24 (-4.00%)
Updated
May 9 closing price
Capitalization
498.67M
82 days until earnings call
Ad is loading...

KROS vs KURA

Header iconKROS vs KURA Comparison
Open Charts KROS vs KURABanner chart's image
Keros Therapeutics
Price$13.65
Change-$0.37 (-2.64%)
Volume$546.35K
Capitalization554.4M
Kura Oncology
Price$5.76
Change-$0.24 (-4.00%)
Volume$742.25K
Capitalization498.67M
KROS vs KURA Comparison Chart
Loading...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KROS vs. KURA commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KROS is a Hold and KURA is a Hold.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (KROS: $13.65 vs. KURA: $5.76)
Brand notoriety: KROS and KURA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KROS: 51% vs. KURA: 56%
Market capitalization -- KROS: $554.4M vs. KURA: $498.67M
KROS [@Biotechnology] is valued at $554.4M. KURA’s [@Biotechnology] market capitalization is $498.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KROS’s FA Score shows that 1 FA rating(s) are green whileKURA’s FA Score has 1 green FA rating(s).

  • KROS’s FA Score: 1 green, 4 red.
  • KURA’s FA Score: 1 green, 4 red.
According to our system of comparison, both KROS and KURA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KROS’s TA Score shows that 5 TA indicator(s) are bullish while KURA’s TA Score has 5 bullish TA indicator(s).

  • KROS’s TA Score: 5 bullish, 5 bearish.
  • KURA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, KURA is a better buy in the short-term than KROS.

Price Growth

KROS (@Biotechnology) experienced а -6.83% price change this week, while KURA (@Biotechnology) price change was -10.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

KROS is expected to report earnings on Jul 31, 2025.

KURA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KROS($554M) has a higher market cap than KURA($499M). KROS YTD gains are higher at: -13.771 vs. KURA (-33.869). KURA has higher annual earnings (EBITDA): -169.5M vs. KROS (-185.82M). KURA has more cash in the bank: 727M vs. KROS (560M). KURA has less debt than KROS: KURA (16.6M) vs KROS (18.9M). KURA has higher revenues than KROS: KURA (53.9M) vs KROS (3.55M).
KROSKURAKROS / KURA
Capitalization554M499M111%
EBITDA-185.82M-169.5M110%
Gain YTD-13.771-33.86941%
P/E RatioN/AN/A-
Revenue3.55M53.9M7%
Total Cash560M727M77%
Total Debt18.9M16.6M114%
FUNDAMENTALS RATINGS
KURA: Fundamental Ratings
KURA
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KROSKURA
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
Bullish Trend 11 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KURA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RDEGX11.360.01
+0.09%
American Funds Dvlpg Wld Gr&Inc R2E
FLUIX26.99N/A
N/A
Fidelity Advisor Stk Selec Lg Cp Val I
WBCCX10.13N/A
N/A
TETON Westwood Balanced C
FRMPX24.49N/A
N/A
Nuveen Small Cap Growth Opp A
MEMJX37.60N/A
N/A
MFS Emerging Markets Equity R6